ES8800691A1 - Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip) - Google Patents

Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)

Info

Publication number
ES8800691A1
ES8800691A1 ES553961A ES553961A ES8800691A1 ES 8800691 A1 ES8800691 A1 ES 8800691A1 ES 553961 A ES553961 A ES 553961A ES 553961 A ES553961 A ES 553961A ES 8800691 A1 ES8800691 A1 ES 8800691A1
Authority
ES
Spain
Prior art keywords
human anti
inhibitor protein
phospholipase inhibitor
inflammatory
inflammatory phospholipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553961A
Other languages
English (en)
Spanish (es)
Other versions
ES553961A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Partners Ltd
Original Assignee
Biotechnology Research Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Partners Ltd filed Critical Biotechnology Research Partners Ltd
Publication of ES8800691A1 publication Critical patent/ES8800691A1/es
Publication of ES553961A0 publication Critical patent/ES553961A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
ES553961A 1985-04-15 1986-04-14 Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip) Expired ES8800691A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72304685A 1985-04-15 1985-04-15

Publications (2)

Publication Number Publication Date
ES8800691A1 true ES8800691A1 (es) 1987-11-16
ES553961A0 ES553961A0 (es) 1987-11-16

Family

ID=24904592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553961A Expired ES8800691A1 (es) 1985-04-15 1986-04-14 Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)

Country Status (6)

Country Link
EP (1) EP0218696A4 (fr)
JP (2) JP2757987B2 (fr)
AU (1) AU5770786A (fr)
CA (1) CA1290267C (fr)
ES (1) ES8800691A1 (fr)
WO (1) WO1986006100A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879224A (en) * 1985-01-10 1989-11-07 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
US4874743A (en) * 1985-01-10 1989-10-17 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
US5081019A (en) * 1985-01-10 1992-01-14 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
US4950646A (en) * 1985-01-10 1990-08-21 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides
JPS6256429A (ja) * 1985-09-04 1987-03-12 Teijin Ltd フオスフオリパ−ゼａ↓２阻害活性を有する蛋白
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
JPH06799B2 (ja) * 1987-04-02 1994-01-05 帝人株式会社 起炎性フオスフオリパ−ゼａ▲下２▼阻害活性を有する蛋白
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
DE69033653T2 (de) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 (Fonden Til Fremme Af Eksperimental Cancerforskning), Kopenhagen Plasminogen-aktivator-rezeptor vom urokinasetyp
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
US5344764A (en) * 1989-08-03 1994-09-06 Teijin Limited Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process
WO1991001999A1 (fr) * 1989-08-03 1991-02-21 Teijin Limited Proteine d'inhibition de la phospholipase a2 naissant dans une region inflammee, sa production et gene prevu a cet effet
WO1991003544A1 (fr) * 1989-08-29 1991-03-21 The Regents Of The University Of California Nouveaux inhibiteurs d'enzymes hydrolytiques, substrats et analyses, methodes et coffrets d'analyses s'y rapportant
DE69432608T2 (de) 1993-06-01 2004-02-26 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Expression von inhibitoren vom plasminogenaktivator vom urokinasetyp
US6248715B1 (en) 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
AU7036398A (en) * 1997-03-20 1998-10-20 Fondazione Centro San Raffaele Del Monte Tabor Upar mimicking peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
JPS6256429A (ja) * 1985-09-04 1987-03-12 Teijin Ltd フオスフオリパ−ゼａ↓２阻害活性を有する蛋白

Also Published As

Publication number Publication date
JPS63500561A (ja) 1988-03-03
JP2637709B2 (ja) 1997-08-06
JP2757987B2 (ja) 1998-05-25
EP0218696A4 (fr) 1989-08-16
CA1290267C (fr) 1991-10-08
JPH08187087A (ja) 1996-07-23
EP0218696A1 (fr) 1987-04-22
ES553961A0 (es) 1987-11-16
AU5770786A (en) 1986-11-05
WO1986006100A1 (fr) 1986-10-23

Similar Documents

Publication Publication Date Title
ES8800691A1 (es) Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)
DK448286A (da) Methionin-aminopeptidase og fremgangsmaade til fremstilling af sammefra bakterier samt fremgangsmaade til fremstilling af rekombinant protein uden n-terminal methionin
AU639910B2 (en) Recombinant immunoglobin preparations
AU573735B2 (en) Peptide analogue enzyme inhibitors
AU584608B2 (en) DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
MY102546A (en) Human immune interferon
IT1208603B (it) Procedimento per indurre protoginia in piante di zea mays e relativo zea mays protogino.
DE3650396D1 (de) Hirudinderivate.
ES8802235A1 (es) Procedimiento para preparar un polipeptido
IT8523049A0 (it) Da esteri e da ammidi di inibitori della renina costituiti amminoacidi.
ES541774A0 (es) Esteres de aminoacidos y de peptidos cromogenos
ES541775A0 (es) Esteres de aminoacidos y de peptidos cromogenos
AU7554487A (en) Cloning and expression of acidic fibroblast growth factor
AU6103086A (en) Cloning and characterization of the bovine interleukin-2 gene
AU577856B2 (en) Cloning and characterization of the human interleukin 1 gene
AU5417590A (en) Novel proteins and cloned genes for diagnosis and prophylaxis of babesiosis
IL76194A (en) 4,5-dihydro-4-oxo-2-((2-trans-phenyl cyclopropyl)amino)-3-furancarboxylic acids and derivatives
DE3585890D1 (de) Peptid und dafuer kodierendes gen.
ES2089177T3 (es) Nuevos peptidos inhibidores.
PT86034A (de) Klonierung und verwendung des transminase-gens ilve
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
ES8606502A1 (es) Un procedimiento para preparar un vector de expresion de un plasmido de levadura
EP0204775A4 (fr) Inhibiteur aux amino-acides et aux peptides de l'elastase leucocytique humaine.
DK313385D0 (da) Intakt gen og fremgangsmaade til udskaering og kloning deraf
AU1996388A (en) Proteins and protein compositions and their use